|
WO2009149012A1
|
|
Laidlomycin compositions and methods
|
|
US2009304793A1
|
|
Sustained release opioid formulations and methods of use
|
|
WO2009032270A2
|
|
A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer
|
|
WO2008123898A1
|
|
Maduramicin compositions and methods
|
|
WO2009023013A1
|
|
Praziquantel and cmetidine compositions and methods
|
|
WO2009023014A1
|
|
Emamectin compositions and methods
|
|
US2008233156A1
|
|
Pharmaceutical compositions
|
|
WO2008100262A1
|
|
Medicated feed premix comprising chlortetracycline hydrochloride
|
|
EP1909769A2
|
|
Alcohol resistant pharmaceutical formulations
|
|
WO2006133349A2
|
|
Orally disintegrable sleep aid formulations
|
|
US2008193537A1
|
|
Morphine Sulfate Formulations
|
|
WO2006052454A1
|
|
Propranolol formulations
|
|
WO2006052405A1
|
|
Propranolol formulations
|
|
EP1791531A1
|
|
Paroxetine formulations
|
|
EP1703898A2
|
|
Ziprasidone formulations
|
|
EP1732513A2
|
|
Rosiglitazone formulations
|
|
EP1841414A1
|
|
Rosiglitazone and metformin formulations
|
|
WO2005065662A1
|
|
Solid dosage formulations of galantamine
|
|
WO2005041935A1
|
|
Pharmaceutical formulations containing quetiapine
|
|
CN1780558A
|
|
Method for formulation of microbial feed additives with feed
|
